Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| -$38.72M— | —— | —— | —— | —— | ||
| $8.03M+0.9% | $8.13M-5.6% | $8.06M-17.9% | $7.78M-29.2% | $7.95M-39.6% | ||
| $10.16M+63.8% | $9.94M+83.4% | $8.88M+83.9% | $7.09M+62.5% | $6.2M+71.7% | ||
| —— | $3.16M+129% | $545K+103% | $7.97M+132% | $257K+101% | ||
| $13.42M-27.1% | $14.03M— | $14.94M— | $16.76M— | $18.4M— | ||
| -$6.42M+65.1% | -$7.03M+67.8% | -$14.94M-48.6% | -$16.76M-73.9% | -$18.4M-282% | ||
| —— | —— | —— | $29.91M-75.8% | $0-100% | ||
| $6.83M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
